HUE061138T2 - Gyulladásgátló gyógyszert és egy dicer aktivátort tartalmazó készítmények idegbetegségek kezelésében történõ alkalmazásra - Google Patents
Gyulladásgátló gyógyszert és egy dicer aktivátort tartalmazó készítmények idegbetegségek kezelésében történõ alkalmazásraInfo
- Publication number
- HUE061138T2 HUE061138T2 HUE18753256A HUE18753256A HUE061138T2 HU E061138 T2 HUE061138 T2 HU E061138T2 HU E18753256 A HUE18753256 A HU E18753256A HU E18753256 A HUE18753256 A HU E18753256A HU E061138 T2 HUE061138 T2 HU E061138T2
- Authority
- HU
- Hungary
- Prior art keywords
- compositions
- treatment
- inflammatory drug
- neuronal diseases
- dicer activator
- Prior art date
Links
- 239000012190 activator Substances 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 229940124599 anti-inflammatory drug Drugs 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001537 neural effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762522157P | 2017-06-20 | 2017-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE061138T2 true HUE061138T2 (hu) | 2023-05-28 |
Family
ID=63168461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18753256A HUE061138T2 (hu) | 2017-06-20 | 2018-06-20 | Gyulladásgátló gyógyszert és egy dicer aktivátort tartalmazó készítmények idegbetegségek kezelésében történõ alkalmazásra |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3641820B1 (hu) |
| JP (1) | JP7270255B2 (hu) |
| AU (1) | AU2018287021B2 (hu) |
| CA (1) | CA3068149C (hu) |
| DK (1) | DK3641820T3 (hu) |
| ES (1) | ES2938895T3 (hu) |
| FI (1) | FI3641820T3 (hu) |
| HU (1) | HUE061138T2 (hu) |
| IL (1) | IL271592B2 (hu) |
| LT (1) | LT3641820T (hu) |
| PL (1) | PL3641820T3 (hu) |
| PT (1) | PT3641820T (hu) |
| WO (1) | WO2018235082A1 (hu) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8372814B2 (en) * | 2004-06-07 | 2013-02-12 | Ista Pharmaceuticals, Inc. | Ophthalmic formulations and uses thereof |
| US10039777B2 (en) * | 2012-03-20 | 2018-08-07 | Neuro-Lm Sas | Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders |
| EP2879678B1 (en) * | 2012-07-31 | 2023-03-01 | Yeda Research and Development Co. Ltd. | Enoxacin for treating amyotrophic lateral sclerosis |
| US9370514B2 (en) * | 2013-08-14 | 2016-06-21 | Board Of Regents, The University Of Texas System | Methods for fine particle manufacture |
| US20150086616A1 (en) * | 2013-09-20 | 2015-03-26 | Steven Lehrer | Method for the prevention and treatment of alzheimer's disease |
-
2018
- 2018-06-20 WO PCT/IL2018/050684 patent/WO2018235082A1/en active Search and Examination
- 2018-06-20 DK DK18753256.9T patent/DK3641820T3/da active
- 2018-06-20 ES ES18753256T patent/ES2938895T3/es active Active
- 2018-06-20 EP EP18753256.9A patent/EP3641820B1/en active Active
- 2018-06-20 PL PL18753256.9T patent/PL3641820T3/pl unknown
- 2018-06-20 LT LTEPPCT/IL2018/050684T patent/LT3641820T/lt unknown
- 2018-06-20 JP JP2019571513A patent/JP7270255B2/ja active Active
- 2018-06-20 IL IL271592A patent/IL271592B2/en unknown
- 2018-06-20 FI FIEP18753256.9T patent/FI3641820T3/fi active
- 2018-06-20 CA CA3068149A patent/CA3068149C/en active Active
- 2018-06-20 PT PT187532569T patent/PT3641820T/pt unknown
- 2018-06-20 HU HUE18753256A patent/HUE061138T2/hu unknown
- 2018-06-20 AU AU2018287021A patent/AU2018287021B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3641820A1 (en) | 2020-04-29 |
| IL271592B2 (en) | 2023-09-01 |
| IL271592B1 (en) | 2023-05-01 |
| AU2018287021A1 (en) | 2020-01-16 |
| PT3641820T (pt) | 2023-02-28 |
| CA3068149A1 (en) | 2018-12-27 |
| LT3641820T (lt) | 2023-02-27 |
| ES2938895T3 (es) | 2023-04-17 |
| WO2018235082A1 (en) | 2018-12-27 |
| JP2020527542A (ja) | 2020-09-10 |
| JP7270255B2 (ja) | 2023-05-10 |
| PL3641820T3 (pl) | 2023-04-11 |
| EP3641820B1 (en) | 2022-12-28 |
| AU2018287021B2 (en) | 2021-09-02 |
| IL271592A (en) | 2020-02-27 |
| DK3641820T3 (da) | 2023-02-06 |
| FI3641820T3 (fi) | 2023-03-01 |
| CA3068149C (en) | 2022-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3577135T3 (pl) | Kompozycja farmaceutyczna do stosowania do leczenia lub zapobiegania chorobom związanym z c5 | |
| HUE049237T2 (hu) | Készítmények a bõr sérülései, rendellenességei és betegségei kezelési eljárásaiban történõ alkalmazásra | |
| DK3335739T3 (en) | Mussel adhesive protein product and the use thereof for the treatment of inflammation of the mucosa | |
| IL266623A (en) | A pharmaceutical preparation for use in the therapeutic treatment of cancer and complications of cancer | |
| EP3694832A4 (en) | EXTENDED-RELEASE PHARMACEUTICAL FORMULATION AND TREATMENT METHODS | |
| EP3268007A4 (en) | Compositions and therapeutic methods for the treatment of complement-associated diseases | |
| IL274578A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| EP3290034A4 (en) | Use of trimethazine in preparation of drugs for preventing and treating liver diseases | |
| HK1257236A1 (zh) | 預防和治療高脂血症的藥物及其用途 | |
| IL270159B (en) | Preparations containing nanometer particles for the administration of drugs for the treatment of eye diseases | |
| EP3456711A4 (en) | CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREFOR | |
| HK1257585A1 (zh) | 預防和治療皮膚纖維化的藥物及其用途 | |
| ZA201903828B (en) | Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases | |
| EP3302464A4 (en) | USE OF CANNABINOIDS IN THE TREATMENT OF INFLAMMATION AND / OR EYE PAIN | |
| IL272495A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| EP3344233A4 (en) | TRANSDERMAL FORMULATIONS FOR THE DELIVERY OF DOXYCLYCLIN AND THEIR USE IN THE TREATMENT OF DOXYCLYCLIN-RELATED ILLNESSES AND SUFFERING | |
| PT3937948T (pt) | Fitoecdisonas e seus derivados para utilização no tratamento de doenças neuromusculares | |
| HK1259382A1 (zh) | 藥物製劑及其用於治療色素性視網膜炎的用途 | |
| PL3515409T3 (pl) | Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych | |
| IL271592B1 (en) | The compositions that combine an anti-inflammatory drug and the action of Dicer for the treatment of neurological diseases. | |
| EP3458058A4 (en) | PHARMACEUTICAL COMPOSITION AND ITS USE IN THE TREATMENT OF AUTOIMMUNE DISEASES | |
| EP3458031A4 (en) | TRANSDERMAL FORMULATIONS FOR THE DELIVERY OF CELECOXIB AND THEIR USE IN THE TREATMENT OF CELCOXIB-SENSITIVE DISEASES AND CONDITIONS | |
| EP3474840A4 (en) | USE OF CYANOGLUCOSIDES AND PHARMACEUTICAL FORMULATIONS THEREOF IN THE TREATMENT OF DIABETES | |
| GB201817346D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of diseases | |
| GB201914886D0 (en) | Medicine/Ailments and diseases |